Stockscreener 앱 받기
195.94
0.48%
0.94
전일 마감가:
$195.00
열려 있는:
$196
하루 거래량:
2.59M
Relative Volume:
0.90
시가총액:
$56.16B
수익:
$21.39B
순이익/손실:
$1.61B
주가수익비율:
35.24
EPS:
5.56
순현금흐름:
$2.55B
1주 성능:
+1.26%
1개월 성능:
+9.89%
6개월 성능:
-12.84%
1년 성능:
-16.27%
1일 변동 폭
$194.64
$196.99
1주일 범위
$190.51
$196.99
52주 변동 폭
$163.33
$251.99
벡톤 디킨슨 Stock (BDX) Company Profile
명칭
Becton Dickinson Co
전화
(201) 847-6800
주소
ONE BECTON DR, FRANKLIN LAKES
BDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
195.94 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ISRG
Intuitive Surgical Inc
|
480.26 | 171.02B | 9.15B | 2.63B | 1.99B | 7.17 |
|
ALC
Alcon Inc
|
87.71 | 42.93B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
284.89 | 41.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.20 | 17.70B | 2.90B | 467.20M | 306.90M | 6.37 |
벡톤 디킨슨 Stock (BDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-05-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-07-11 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-06-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 재개 | Raymond James | Mkt Perform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 재개 | Goldman | Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-07 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-02-07 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-01-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-05-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 개시 | Deutsche Bank | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-06-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-04-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-01-19 | 재개 | BofA/Merrill | Buy |
| 2018-01-05 | 업그레이드 | Citigroup | Sell → Neutral |
| 2018-01-05 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2017-12-29 | 재확인 | Deutsche Bank | Buy |
모두보기
벡톤 디킨슨 주식(BDX)의 최신 뉴스
Becton Dickinson's (NYSE:BDX) Solid Earnings Have Been Accounted For Conservatively - 富途牛牛
Patient Blood Management Market Growth Analysis Report 2025-2033 | AI-Driven Analytics Revolutionize Blood Management Strategies, Blockchain Enhances Supply Transparency and Safety - GlobeNewswire Inc.
Brandes Investment Partners, LP Makes Significant Addition to Becton Dickinson & Co - uk.finance.yahoo.com
Morgan Stanley Forecasts Strong Price Appreciation for Becton, Dickinson and Company (NYSE:BDX) Stock - Defense World
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test - MSN
Becton, Dickinson and Company (NYSE:BDX) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Defense World
Diamond Hill Capital's Strategic Moves: Significant Reduction in Becton Dickinson & Co - Yahoo Finance
Morgan Stanley Reaffirms Their Buy Rating on Becton Dickinson (BDX) - The Globe and Mail
Director’s Bold Move: A Million-Dollar Bet on Becton Dickinson! - TipRanks
Judge OKs Becton Dickinson's $9M Investor Settlement - Law360
Becton Dickinson price target raised to $197 from $196 at Morgan Stanley - TipRanks
Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $197 - 富途牛牛
Becton, Dickinson rises as strong Q3 results lead to guidance raise - MSN
4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential - 24/7 Wall St.
BD Careers | Jobs at BD | We are the Makers of Possible - Becton Dickinson
Earnings Beat: Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - 富途牛牛
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200 - 富途牛牛
Becton, Dickinson and Company (NYSE:BDX) Raised to Buy at Wall Street Zen - Defense World
J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $190 - 富途牛牛
Director Makes Significant Move with Becton Dickinson Stock! - TipRanks
A Quick Look at Today's Ratings for Becton Dickinson & Co(BDX.US), With a Forecast Between $183 to $200 - 富途牛牛
Becton Dickinson: Wells Fargo maintains Equal-Weight, raises PT to $184 from $172. - AInvest
Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call Transcript - Insider Monkey
Becton Dickinson price target raised to $200 from $185 at Piper Sandler - TipRanks
Piper Sandler raises Becton Dickinson stock price target to $200 on earnings beat - Investing.com
William Blair Maintains Becton Dickinson & Co(BDX.US) With Hold Rating - 富途牛牛
BD revenue up 10.4% to USD 5.5 billion in Q3 2025 - Medical Buyer
Becton Dickinson & Co (BDX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Becton Dickinson Reports Strong Q3 2025 Results - TipRanks
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MSN
Becton, Dickinson and Co’s Optimistic Earnings Call - TipRanks
Becton Dickinson: Fiscal Q3 Earnings Snapshot - Chron
Becton Dickinson and Co reports results for the quarter ended June 30Earnings Summary - TradingView
Becton Dickinson Q3 Beats Estimates On Medical Device Boom - inkl
Earnings call transcript: Becton Dickinson Q3 2025 earnings beat forecasts, stock surges - Investing.com
Becton Dickinson Earnings: Return to Organic Growth; Raised EPS Guidance; Shares Remain Undervalued - Morningstar
Becton, Dickinson stock rises on Q3 beat (BDX:NYSE) - Seeking Alpha
Becton, Dickinson and Company 2025 Q3ResultsEarnings Call Presentation (NYSE:BDX) - Seeking Alpha
Becton, Dickinson Boosts FY25 Adj. EPS OutlookUpdate - Nasdaq
Becton Dickinson Q3 FY25 presentation: Organic growth accelerates, guidance raised - Investing.com India
BD raises 2025 EPS guidance after strong Q3 performance - MassDevice
Becton Dickinson & Co Surpasses Q3 Estimates with $5.5 Billion Revenue and $3.68 Adjusted EPS - GuruFocus
BD Reports Third Quarter Fiscal 2025 Financial Results - Placera.se
Becton Dickinson shares surge as Q3 earnings beat drives guidance hike - Investing.com Nigeria
Becton Dickinson & Co Surpasses Q3 Estimates with $5.5 Billion R - GuruFocus
Becton Dickinson earnings beat by $0.28, revenue topped estimates - Investing.com
Becton Dickinson ups FY25 adjusted EPS view to $14.30-$14.45 from $14.06-$14.34 - TipRanks
First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co - Yahoo Finance
Becton, Dickinson Q3 2025 Earnings Preview - MSN
Is Becton Dickinson (NYSE:BDX) A Risky Investment? - 富途牛牛
Stock Analysis | Becton, Dickinson OutlookA Cautious Call Amid Mixed Technical and Analyst Signals - AInvest
벡톤 디킨슨 (BDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.06%
0.37%
자본화:
|
볼륨(24시간):